Skip to content

To see the role of Chinta (Anxiety) as a cause in Shukrakshaya (low sperm count) and the relief with Ayurvedic treatment.

Assessing the role of Chinta (Anxiety) as a hetu in Shukrakshaya (Oligospermea) and the effect of Medhya Rasayan with Svyamguptadi beej churna - A randomised clinical trial.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042277
Enrollment
30
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married male aged between 21 to 50 yrs of age. 2. Subjective parameters based on Shukrakshaya Lakshana. 3. Subjective parameters based on Sexual Health Parameters by Mehra and Singh (1994). 4. Objective parameters based on semen analysis – Sperm Count less than 15 million spermatozoa/ml. (WHO Criteria 5TH Edition). 5. Patients willing to participate in study and follow compliance of study instructions.

Exclusion criteria

Exclusion criteria: 1. Patient suffering from Azoospermea, Aspermea. 2. Infertility due to injury to genital organs. 3. Patients suffering from Varicocele, Hydrocele, Sexually Transmitted Diseases. 4. Patient having Diabetes Mellitus. 5. Genetic Disorders like Klinfelter’s Syndrome.

Design outcomes

Primary

MeasureTime frame
Subjective 1. Relief in the Chinta (Anxiety) based on assessment of Hamilton anxiety rating scale. 2. Relief in Lakshana of Shukrakshaya. (Questionnaire will be prepared and validated). 3. Sexual Health Parameters i.e Desire, Erection, Rigidity, Ejaculation and orgasm will be recorded.( Mehra and Singh 1994). Objective 1. Relief based on observation of Semen Analysis i.e. Count, Liquefaction Time, Viscosity, Motility, Morphology. Timepoint: Baseline, 30 days, 60 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Anand More

All India Institute of Ayurveda

drmoreanand@gmail.com9422025732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026